Literature DB >> 31907154

[Application of intracranial lead reconstruction in deep brain stimulation therapy in patients with Parkinson's disease].

Xiaobin Zheng1, Lianghong Yu1, Xinlong Wan2, Huiqing Wang1, Ting Yu1, Qiu He1, Zhangya Lin1, Dezhi Kang1.   

Abstract

OBJECTIVE: To evaluate the feasibility of applying intracranial lead reconstruction in deep brain stimulation (DBS) therapy for Parkinsonism.
METHODS: We retrospectively collected the clinical data from 27 patients with Parkinson's disease (PD), who received bilateral subthalamic nucleus (STN) DBS therapy between January, 2016 and December, 2017. According to the position of the selected optimal stimulating contact of the implanted leads, the patients were divided into group A with the stimulating contacts of the bilateral leads in the STN, group B with unilateral stimulating contacts in the STN, and group C with bilateral stimulating contacts outside the STN. All the patients were assessed for improvement using Hoehn-Yahr stage, the third part of United Parkinson's Disease Rating Scale (UPDRS Ⅲ), Schwab and England Activities of Daily Living (SE-ADL), and L-dopa equivalent daily dose (LEDD). The consistency between the optimal stimulating contact selected by lead reconstruction and that by standard postoperative programming procedure was also evaluated.
RESULTS: The patients in all the 3 groups showed postoperative improvements in Hoehn-Yahr stage, UPDRS Ⅲ score, SE-ADL score, and LEDD in the medication-off state. But at 12 months of the follow-up, such improvements were maintained only in the patients of group A. The optimal stimulating contacts selected by lead reconstruction and standard postoperative programming procedure had a matching rate of up to 77.78% (42/54), and the coordinates of the optimal contacts selected by the two methods showed no significant difference.
CONCLUSIONS: Intracranial lead reconstruction facilitates the study of the association between the implant site of the leads and the clinical outcome of DBS therapy for PD and allows the precise selection of the optimal contact of the implanted leads in postoperative programming of DBS.

Entities:  

Keywords:  Parkinson's disease; deep brain stimulation; electrode implantation position; lead reconstruction

Mesh:

Year:  2019        PMID: 31907154      PMCID: PMC6942991          DOI: 10.12122/j.issn.1673-4254.2019.12.10

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  26 in total

1.  Subthalamic stimulation for Parkinson disease: determination of electrode location necessary for clinical efficacy.

Authors:  Shearwood McClelland; Blair Ford; Patrick B Senatus; Linda M Winfield; Yunling E Du; Seth L Pullman; Qiping Yu; Steven J Frucht; Guy M McKhann; Robert R Goodman
Journal:  Neurosurg Focus       Date:  2005-11-15       Impact factor: 4.047

2.  Deep brain stimulation activation volumes and their association with neurophysiological mapping and therapeutic outcomes.

Authors:  C B Maks; C R Butson; B L Walter; J L Vitek; C C McIntyre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-04-10       Impact factor: 10.154

Review 3.  Precision medicine for disease modification in Parkinson disease.

Authors:  Alberto J Espay; Patrik Brundin; Anthony E Lang
Journal:  Nat Rev Neurol       Date:  2017-01-20       Impact factor: 42.937

4.  Clinical characteristics and quality of life in Chinese patients with Parkinson's disease beyond 20 years.

Authors:  Ruwei Ou; Yanbing Hou; Wei Song; Qianqian Wei; Yongping Chen; Bei Cao; Xiaoqin Yuan; Huifang Shang
Journal:  Neurol Res       Date:  2018-02-15       Impact factor: 2.448

5.  Deep brain stimulation for Parkinson's disease: defining the optimal location within the subthalamic nucleus.

Authors:  Maarten Bot; P Richard Schuurman; Vincent J J Odekerken; Rens Verhagen; Fiorella Maria Contarino; Rob M A De Bie; Pepijn van den Munckhof
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-01-20       Impact factor: 10.154

6.  Stimulation site within the MRI-defined STN predicts postoperative motor outcome.

Authors:  Fritz Wodarg; Jan Herzog; René Reese; Daniela Falk; Markus O Pinsker; Frank Steigerwald; Olav Jansen; Günther Deuschl; H Maximillian Mehdorn; Jens Volkmann
Journal:  Mov Disord       Date:  2012-04-19       Impact factor: 10.338

7.  Quality of Life and Caregivers' Burden of Parkinson's Disease.

Authors:  Kingston Rajiah; Mari Kannan Maharajan; Si Jen Yeen; Sara Lew
Journal:  Neuroepidemiology       Date:  2017-07-21       Impact factor: 3.282

8.  Magnetic resonance and computed tomography image fusion technology in patients with Parkinson's disease after deep brain stimulation.

Authors:  Jun Xia; Pin He; Xiaodong Cai; Doudou Zhang; Ni Xie
Journal:  J Neurol Sci       Date:  2017-09-08       Impact factor: 3.181

Review 9.  Deep brain stimulation: foundations and future trends.

Authors:  David J Aum; Travis S Tierney
Journal:  Front Biosci (Landmark Ed)       Date:  2018-01-01

Review 10.  Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: The Effect of Varying Stimulation Parameters.

Authors:  Viswas Dayal; Patricia Limousin; Thomas Foltynie
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.